Developing vaccines to protect against future pandemics
Official title: The UCI Vaccines for Pandemic Preparedness Center (VPPC)
Funded at University of California-Irvine · NIH-10863336 · Data updated 2026-11-12
This study is working on making quick and safe vaccines to help protect people from new diseases, especially those who are most at risk, while also teaching future scientists how to keep improving vaccine development for better health security.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project start | August 20, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $33,116,067 |
| NIH project number | 1U19AI181968-01 |
| Project ID | NIH-10863336 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit include individuals in high-risk groups for infectious diseases, such as the elderly, immunocompromised individuals, and frontline healthcare workers.
✕Less likely to help
Patients who are not at risk for infectious diseases or those who do not receive vaccinations may not benefit from this research.
What this research studies
This research focuses on creating safe and effective vaccines that can be rapidly deployed to protect vulnerable populations from emerging infectious diseases. The approach emphasizes agility in vaccine development, aiming to produce vaccines within 100 days of identifying a new pathogen. The project also includes educational initiatives to train future vaccine scientists, ensuring ongoing advancements in pandemic preparedness. By leveraging lessons learned from past outbreaks, particularly COVID-19, the research aims to enhance global health security.
Why it matters
Potential benefit: If successful, this research could lead to the rapid availability of vaccines that protect against future pandemics, potentially saving countless lives.
How similar studies have gone: Previous research has shown success in rapid vaccine development during the COVID-19 pandemic, indicating that this approach has potential for future applications.
Where this research is happening
-
University of California-Irvine
Irvine, United States Active
Researchers
- Principal investigator: Felgner, Philip Louis — University of California-Irvine
- Study coordinator: Felgner, Philip Louis
Related research
Other NIH-funded projects on the same topics.
-
Retinal cell grafts to restore sight in AMD and RP
A patient-focused program aims to replace damaged retinal cells with organized, transplant-ready sheets created from stem cells to improve vision in age-related macular degeneration and related diseases.
-
Treg-based tolerance to dystrophin immune responses in Duchenne muscular dystrophy
A new grant aims to help people with Duchenne muscular dystrophy by teaching the immune system to tolerate the dystrophin treatment delivered by gene therapy.
-
Immune and NGF factors in Alzheimer’s for adults with Down syndrome
This grant studies why people with Down syndrome develop Alzheimer’s disease by looking at immune signals and nerve growth factor problems.
-
Promoting Heart Cell Maturation with Light-Activated Engineered Peptides
Aims to help grown heart cells from stem cells mature more like real adult heart tissue using special peptide coatings that respond to light.
-
Understanding how heart nerves affect dangerous heart rhythms after a heart attack
This NIH grant studies how changes in the heart’s nerve signaling after a heart attack lead to dangerous rhythm problems, with the goal of finding ways to prevent them.
-
All of Us Southern California Consortium supports broad participation in a national health data program
A national health data program in Southern California works to recruit and retain adults to share health information and participate in research that uses this data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.